Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Breast MR imaging: validated indications and unsolved problems].

Sophie Taïeb1, Luc Ceugnart

  • 1Département d'imagerie, Centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59000 Lille, France. s-taieb@o-lambret.fr

Bulletin Du Cancer
|January 31, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound-guided blue dye localization of a clipped axillary lymph node after neoadjuvant chemotherapy in breast cancer a prospective feasibility study and critical review of axillary localization techniques.

Surgical oncology·2026
Same author

Inventory and needs assessment in francophone LMICs for education, screening and optimal management of breast cancer. The ELISA study.

Bulletin du cancer·2026
Same author

Radiation-Induced Breast Cancer Attributable to Mammography Screening: Estimation for France in 2019.

Journal of breast imaging·2026
Same author

[Prevalence of breast arterial calcification in women who underwent a breast cancer screening in the Hauts-de-France].

Bulletin du cancer·2025
Same author

Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.

Radiology·2025
Same author

Imaging Findings of Solitary Fibrous Tumors of the Gallbladder.

Acta medica (Hradec Kralove)·2025
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
See all related articles

Breast MRI is valuable but has limitations. High sensitivity causes false positives, and image-guided biopsies are challenging for subtle lesions, necessitating careful clinical application.

Area of Science:

  • Radiology
  • Medical Imaging
  • Oncology

Background:

  • Breast Magnetic Resonance Imaging (MRI) is a crucial tool for assessing breast pathology.
  • Its role as a supplementary diagnostic method after initial mammography and ultrasound is established.
  • Challenges exist in its application, particularly concerning interpretation and interventional procedures.

Purpose of the Study:

  • To evaluate the established contribution of breast MRI in the diagnostic workup of breast pathologies.
  • To identify and analyze the primary limitations of breast MRI in clinical practice.
  • To emphasize the importance of reasoned application of breast MRI based on validated clinical indications.

Main Methods:

  • Review of the established utility of breast MRI as a second-intention assessment tool.

Related Experiment Videos

  • Analysis of reported sensitivity and specificity, focusing on false positive rates.
  • Evaluation of the technical difficulties and success rates of image-guided biopsies under MRI.

    • Main Results:

    • Breast MRI demonstrates significant contribution in second-intention assessments.
    • High sensitivity leads to a considerable false positive rate, ranging from 20% to 40%.
    • Image-guided biopsies for MRI-detected lesions not visible on conventional imaging present difficulties, with success rates between 50% and 75%.

    Conclusions:

    • Breast MRI is a powerful diagnostic modality but requires careful interpretation due to its high sensitivity.
    • The challenges in performing MRI-guided biopsies for subtle lesions necessitate a judicious approach.
    • Reasoned use of breast MRI, adhering to validated clinical indications, is imperative to optimize patient care and avoid potential iatrogenic harm.